Medications for Weight Loss and MASLD
Gene Y. Im(Icahn School of Medicine at Mount Sinai), Meena B. Bansal(Mount Sinai Hospital), Brian T. Lee(Hoag Memorial Hospital Presbyterian), Thomas G. Cotter(University College Cork), Jessica L. Mellinger(Henry Ford Health System), Aparna Goel(Stanford University), Blanca Lizaola‐Mayo(WinnMed), Elizabeth S. Aby(University of Minnesota), Courtney B. Sherman(University of California, San Francisco), Jonathan G. Stine(Pennsylvania State University), Lamia Haque(Yale University), Shaun Chandna(University of Utah), Manhal Izzy(Vanderbilt University Medical Center), Jay Luther(Massachusetts General Hospital), Po‐Hung Chen(Johns Hopkins University), John P. Rice(University of Wisconsin–Madison), Amon Asgharpour, Ashwani K. Singal(University of Louisville), Loretta Jophlin(University of Louisville)
Cited by 1
Related Papers
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
|New England Journal of Medicine|2017|565
ACG Clinical Guideline: Alcohol-Associated Liver Disease
|The American Journal of Gastroenterology|2023|227
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension
|Clinical Gastroenterology and Hepatology|2021|221